MedPath

Saphmustin

Brand Name: Saphmustin

Generic Name: Bendamustine Hydrochloride

Active
Registration Number

DRP-15540

Dosage Form

Lyophilized Powder For Concentrate For I.V. Infusion

Issuance Date

July 31, 2024

Expiry Date

July 31, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 mg
PackagingType 1 Amber Glass Vial x 60 mL (Box of 1's and Box of 5's) F

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic (Alkylating Agent)
A
Application
Initial (Rx)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Bendamustine HydrochlorideActive
Monograph: Bendamustine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform